The expression of CD117, Oct4 and JAGGED was significantly up in paclitaxel-treated ascites tumor cells, while there was a trend in the increased expression of EpCAM, CD44 and NANOG but it was not significant compared to untreated control. This evidence concerns the gene KIT and neoplasm.